Related Experiment Video
Updated: May 3, 2026
Visualizing Scar Development Using SCAD Assay - An Ex-situ Skin Scarring Assay
Published on: April 28, 2022
Targeted Antiscarring Therapy for Tissue Injuries
Tero A H Järvinen1, Erkki Ruoslahti2
1Vascular Mapping Laboratory, Center for Nanomedicine, Sanford-Burnham Medical Research Institute at UCSB, University of California , Santa Barbara, California. ; Cancer Research Center, Sanford-Burnham Medical Research Institute , La Jolla, California. ; Department of Orthopaedic Surgery, University of Tampere and Tampere City Hospital , Tampere, Finland .
Significance:
The healing of injuries, such as those caused by ischemia (myocardial infarction, stroke), trauma, surgery, and inflammation, tends to happen through undesirable and harmful scarring. Current options in reducing scar formation are largely limited to local intervention in accessible tissues.
Recent Advances:
We have designed a systemically administered, injury-targeted decorin for scar prevention. The delivery of decorin to injured tissues is achieved by fusing recombinant decorin to a 9-amino acid peptide, CARSKNKDC (CAR), which specifically recognizes the vessels in injured tissues and extravasates into the tissue, delivering decorin with it.
Critical Issues:
Decorin is known to prevent tissue fibrosis and promote tissue regeneration. This activity of decorin is based on inhibition of TGF-β and some other regulatory activities. In addition to serving as a delivery vehicle, the CAR component endowed decorin with much stronger neutralizing activity against TGF-β1 in vitro than is obtained with nontargeted decorin. The CAR-decorin fusion protein promoted wound healing in a mouse skin wound model and suppressed scar formation at doses at which nontargeted decorin was inactive. These results show that selective targeting enhances specificity and potency of an antiscarring compound.
Future Directions:
Targeted decorin provides a new, systemic option for the treatment of scarring and fibrotic diseases.
Insights
Targeted decorin prevents harmful scarring after injuries like heart attacks and strokes. This novel systemic treatment enhances healing and reduces fibrosis, offering a new option for scar prevention.
Area of Science:
- Biomedical Engineering
- Regenerative Medicine
- Wound Healing Research
Background:
- Uncontrolled scarring impedes healing after injuries such as myocardial infarction, stroke, trauma, and surgery.
- Current scar reduction methods are limited to local applications in accessible tissues.
Approach:
- A novel systemically administered, injury-targeted decorin system was developed for scar prevention.
- Decorin was fused to a peptide (CARSKNKDC) that targets injured tissue vasculature for enhanced delivery.
Key Points:
- Decorin inhibits TGF-β, preventing fibrosis and promoting regeneration.
- The CAR peptide enhances decorin's TGF-β neutralizing activity and targets it to injury sites.
- CAR-decorin significantly improved wound healing and suppressed scarring in a mouse model.
Conclusions:
- Targeted decorin demonstrates enhanced specificity and potency for scar prevention compared to non-targeted decorin.
- This approach offers a new systemic therapeutic strategy for treating scarring and fibrotic diseases.
Related Concept Videos
01:19Clinical Applications of Epidermal Stem Cells
01:11Healing I: Introduction
01:21Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
01:24Healing II: Complications
01:19Overview of Regeneration and Repair
Regeneration
All animals have varying degrees of...
01:28Phases of Wound Repair
Formation of Blood Clot
In case of deep injuries, trauma to blood vessels results in blood loss. In the meantime, phospholipids released from the ruptured endothelial cellular membrane are converted into arachidonic...